These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 8445499

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Validation--mission completed?
    Sharp J.
    J Parenter Sci Technol; 1993; 47(1):2-3. PubMed ID: 8445494
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. FDA transparency rules could hit small companies hardest.
    Allison M.
    Nat Biotechnol; 2010 Aug; 28(8):767-8. PubMed ID: 20697386
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. "Safer, but not safe enough".
    Crombie HD.
    Conn Med; 2006 Aug; 70(10):645. PubMed ID: 17190395
    [No Abstract] [Full Text] [Related]

  • 10. Vioxx may go back on sale after scraping past FDA panel.
    Wadman M.
    Nature; 2005 Feb 24; 433(7028):790. PubMed ID: 15729304
    [No Abstract] [Full Text] [Related]

  • 11. Drug reactions: the role of the package insert.
    Barnett FJ.
    J Leg Med (N Y); 1973 Feb 24; 1(1):19-23. PubMed ID: 4548069
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Diagnostic x-ray equipment performance standard; request for comments and information--FDA. Advance notice of proposed rulemaking.
    Fed Regist; 1997 Dec 11; 62(238):65235-7. PubMed ID: 10176581
    [Abstract] [Full Text] [Related]

  • 14. Recommendations for the labeling of large volume parenterals. National Coordinating Committee on Large Volume Parenterals.
    Am J Hosp Pharm; 1978 Jan 11; 35(1):49-51. PubMed ID: 623118
    [Abstract] [Full Text] [Related]

  • 15. Drug defect reporting program.
    Valentino JG.
    Bull Parenter Drug Assoc; 1975 Jan 11; 29(2):55-63. PubMed ID: 1120213
    [No Abstract] [Full Text] [Related]

  • 16. PDA comments on draft guidance for industry on changes to an approved NDA or ANDA. Parenteral Drug Association.
    PDA J Pharm Sci Technol; 1999 Jan 11; 53(5):264-72. PubMed ID: 10754723
    [No Abstract] [Full Text] [Related]

  • 17. Pharmaceutical GMPs.
    Bobrowicz G.
    Qual Assur; 1994 Jun 11; 3(2):138-48. PubMed ID: 7804629
    [No Abstract] [Full Text] [Related]

  • 18. An interview with FDA commissioner Hayes.
    Small WE.
    Am Pharm; 1981 Oct 11; NS21(10):27-36. PubMed ID: 6803557
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Amendment to the current good manufacturing practice regulations for finished pharmaceuticals. Direct final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2007 Dec 04; 72(232):68064-70. PubMed ID: 18064770
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.